Platelets are highly efficient and efficacious carriers for tumor-targeted nano-drug delivery

References

• Banerjee M, Huang Y, Joshi S, et al. (2020). Platelets endocytose viral particles and are activated via TLR (Toll-Like Receptor) signaling. Arterioscler Thromb Vasc Biol 40:1635–50.
   PubMed Web of Science ®Google Scholar
• Catani MV, Savini I, Tullio V, et al. (2020). The "Janus Face" of platelets in cancer. IJMS 21:788.
   Web of Science ®Google Scholar
• Combes F, Meyer E, Sanders NN. (2020). Immune cells as tumor drug delivery vehicles. J Control Release 327:70–87.
   PubMed Web of Science ®Google Scholar
• D'Alessandro R, Messa C, Refolo MG, et al. (2015). Modulation of sensitivity and resistance to multikinase inhibitors by microenvironmental platelet factors in HCC. Expert Opin Pharmacother 16:2773–80.
   PubMed Web of Science ®Google Scholar
• Davizon-Castillo P, Rowley JW, Rondina MT. (2020). Megakaryocyte and platelet transcriptomics for discoveries in human health and disease. Arterioscler Thromb Vasc Biol 40:1432–40.
   PubMed Web of Science ®Google Scholar
• Fan C, Georgiou KR, Morris HA, et al. (2017). Combination breast cancer chemotherapy with doxorubicin and cyclophosphamide damages bone and bone marrow in a female rat model. Breast Cancer Res Treat 165:41–51.
   PubMed Web of Science ®Google Scholar
• Golebiewska EM, Poole AW. (2015). Platelet secretion: from haemostasis to wound healing and beyond. Blood Rev29:153–62.
   PubMed Web of Science ®Google Scholar
• Gresele P, Momi S, Malvestiti M, et al. (2017). Platelet-targeted pharmacologic treatments as anti-cancer therapy. Cancer Metastasis Rev 36:331–55.
   PubMed Web of Science ®Google Scholar
• Haemmerle M, Stone RL, Menter DG, et al. (2018). The platelet lifeline to cancer: challenges and opportunities. Cancer Cell 33:965–83.
   PubMed Web of Science ®Google Scholar
• Harrison P, Cramer EM. (1993). Platelet alpha-granules. Blood Rev 7:52–62.
   PubMed Web of Science ®Google Scholar
• Holinstat M. (2017). Normal platelet function. Cancer Metastasis Rev 36:195–8.
   PubMed Web of Science ®Google Scholar
• Ho-Tin-Noé B, Goerge T, Wagner DD. (2009). Platelets: guardians of tumor vasculature. Cancer Res 69:5623–6.
   PubMed Web of Science ®Google Scholar
• Huijbers EJ, van Beijnum JR, Thijssen VL, et al. (2016). Role of the tumor stroma in resistance to anti-angiogenic therapy. Drug Resist Updat 25:26–37.
   PubMed Web of Science ®Google Scholar
• Jia G, Kong J, Yao C, et al. (2020). Platelet lysates in Hepatocellular Carcinoma patients after radiofrequency ablation facilitate tumor proliferation, invasion and vasculogenic mimicry. Int J Med Sci 17:2104–12.
   PubMed Web of Science ®Google Scholar
• Key NS, Khorana AA, Kuderer NM, et al. (2020). Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol 38:496–520.
   PubMed Web of Science ®Google Scholar
• Koupenova M, Clancy L, Corkrey HA, Freedman JE. (2018). Circulating platelets as mediators of immunity, inflammation, and thrombosis. Circ Res 122:337–51.
   PubMed Web of Science ®Google Scholar
• Lefrançais E, Looney MR. (2019). Platelet biogenesis in the lung circulation. Physiology 34:392–401.
   PubMed Web of Science ®Google Scholar
• Li Z, Di C, Li S, et al. (2019). Smart nanotherapeutic targeting of tumor vasculature. Acc Chem Res 52:2703–12.
   PubMed Web of Science ®Google Scholar
• Li TF, Li K, Wang C, et al. (2017). Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment. J Control Release 268:128–46.
   PubMed Web of Science ®Google Scholar
• Li TF, Li K, Zhang Q, et al. (2018). Dendritic cell-mediated delivery of doxorubicin-polyglycerol-nanodiamond composites elicits enhanced anti-cancer immune response in glioblastoma. Biomaterials 181:35–52.
   PubMed Web of Science ®Google Scholar
• Li W, Su Z, Hao M, et al. (2020). Cytopharmaceuticals: an emerging paradigm for drug delivery. J Control Release 328:313–24.
   PubMed Web of Science ®Google Scholar
• Li TF, Xu YH, Li K, et al. (2019). Doxorubicin-polyglycerol-nanodiamond composites stimulate glioblastoma cell immunogenicity through activation of autophagy. Acta Biomater 86:381–94.
   PubMed Web of Science ®Google Scholar
• Li Q, Zhou Y, He W, et al. (2021). Platelet-armored nanoplatform to harmonize janus-faced IFN-γ against tumor recurrence and metastasis. J Control Release 338:33–45.
   PubMed Web of Science ®Google Scholar
• Lu Y, Hu Q, Jiang C, et al. (2019). Platelet for drug delivery. Curr Opin Biotechnol 58:81–91.
   PubMed Web of Science ®Google Scholar
• Lv Y, Li F, Wang S, et al. (2016). Near-infrared light-triggered platelet arsenal for combined photothermal-immunotherapy against cancer. Sci Adv 7:eabd7614.
   Web of Science ®Google Scholar
• Machlus KR, Italiano JE. Jr. (2013). The incredible journey: from megakaryocyte development to platelet formation. J Cell Biol 201:785–96.
   PubMed Web of Science ®Google Scholar
• Miao S, Lu M, Liu Y, et al. (2020). Platelets are recruited to hepatocellular carcinoma tissues in a CX3CL1-CX3CR1 dependent manner and induce tumour cell apoptosis. Mol Oncol 14:2546–59.
   PubMed Web of Science ®Google Scholar
• Minderman H, Linssen P, van der Lely N, et al. (1994). Toxicity of idarubicin and doxorubicin towards normal and leukemic human bone marrow progenitors in relation to their proliferative state. Leukemia 8:382–7.
   PubMed Web of Science ®Google Scholar
• Plantureux L, Mège D, Crescence L, et al. (2020). The interaction of platelets with colorectal cancer cells inhibits tumor growth but promotes metastasis. Cancer Res 80:291–303.
   PubMed Web of Science ®Google Scholar
• Sarkar S, Alam MA, Shaw J, et al. (2013). Drug delivery using platelet cancer cell interaction. Pharm Res 30:2785–94.
   PubMed Web of Science ®Google Scholar
• Schlesinger M. (2018). Role of platelets and platelet receptors in cancer metastasis. J Hematol Oncol 11:125.
   PubMed Web of Science ®Google Scholar
• Suzuki-Inoue K. (2019). Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin. Blood 134:1912–8.
   PubMed Web of Science ®Google Scholar
• Wang C, Li K, Li T, et al. (2018). Monocyte-mediated chemotherapy drug delivery in glioblastoma. Nanomedicine (Lond) 13:157–78.
   PubMed Web of Science ®Google Scholar
• Xu XR, Yousef GM, Ni H. (2018). Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents. Blood 131:1777–89.
   PubMed Web of Science ®Google Scholar
• Xu P, Zuo H, Chen B, et al. (2017). Doxorubicin-loaded platelets as a smart drug delivery system: an improved therapy for lymphoma. Sci Rep 7:42632.
   PubMed Web of Science ®Google Scholar
• Yan M, Lesyk G, Radziwon-Balicka A, et al. (2014). Pharmacological regulation of platelet factors that influence tumor angiogenesis. Semin Oncol 41:370–7.
   PubMed Web of Science ®Google Scholar
• Ying M, Zhuang J, Wei X, et al. (2018). Remote-Loaded Platelet Vesicles for Disease-Targeted Delivery of Therapeutics. Adv Funct Mater 28:1801032.
   PubMed Web of Science ®Google Scholar
• Zhao L, Xu YH, Akasaka T, et al. (2014). Polyglycerol-coated nanodiamond as a macrophage-evading platform for selective drug delivery in cancer cells. Biomaterials 35:5393–406.
   PubMed Web of Science ®Google Scholar
• Zuo XX, Yang Y, Zhang Y, et al. (2019). Platelets promote breast cancer cell MCF-7 metastasis by direct interaction: surface integrin α2β1-contacting-mediated activation of Wnt-β-catenin pathway. Cell Commun Signal 17:142.
   PubMed Web of Science ®Google Scholar